Seeking Alpha

Andy Batts

View as an RSS Feed
View Andy Batts' Comments BY TICKER:
Latest  |  Highest rated
  • Why I Would Rather Own Amazon Than Alibaba [View article]
    Michael Moritz, the chairman of VC firm Sequoia Capital, described the Alibaba IPO as a “major landmark event” that is as significant as the Google IPO, and said Chinese internet companies will create "one global battlefield" with western companies over the next decade. He warned that a lot of US and European companies are still denying the significance of Chinese internet companies, and that the Alibaba IPO will only make more people aware of the booming Chinese tech industry.
    Sep 19 02:08 PM | 2 Likes Like |Link to Comment
  • Apple Take Note - Samsung Has Not Gone Away [View article]

    Brilliant! But I see AAPL @ $110 just after the iPhone 6 release. Read my bearish prediction after the iPhone 5 release by clicking the following link.
    This time I'm bullish.
    Sep 4 03:00 PM | Likes Like |Link to Comment
  • Update: Cepheid Received CE-IVD Mark For Xpert TV Test [View article]
    Dear Glads,

    Sorry for the inconvenience. IVD (In Vitro Diagnostics) devices are regulated by EU Directive 98/79/EC of 27, October 1998. Examples of IVD devices include reactors, instruments, or other devices used for examining sample material from the human body, including blood and tissue samples, for the exclusive or primary purpose of providing information to ensure a correct patient diagnosis.

    The CE-mark is a requirement for selling medical products and equipment in the EU. Additionally, an increasing number of other markets internationally require CE-marking.

    IVD Directive compliance requires that a product is correctly classified. The Directive defines products into List A or List B. DGM is appointed as notified body for IVD devices under the IVD Medical Devices Directive, and can assess and certify quality systems to allow CE marking of products according to the IVD Directive. Hope this helps. Thanks.

    Sep 4 01:51 PM | Likes Like |Link to Comment
  • Update: Johnson & Johnson Facing New Lawsuits On Pinnacle Hips [View article]
    Dear DoctoRx, my reasoning is simple. JNJ is a mega-cap stock that hardly offers significant buy-able dips, and I believe that the recent negative news flow is a shorting opportunity for some investors, who are short-term players. A "direction" of a stock price is the resultant force of different forces, so "Why should retail SA investors pick up their cast-off inventory?" seems invalid to me.

    "Why this new problem isn't a reason to lighten up on JNJ?" -- Well, in spite of the "huge damages" these are minor problems for a $292 billion company.

    Sep 4 01:40 PM | Likes Like |Link to Comment
  • Update: Horsehead Raises $50 Million For Potential Acquisitions - Book Partial Profits [View article]
    Hi Burt,

    I had a small trading position that I exited on the news.

    Aug 28 03:50 AM | Likes Like |Link to Comment
  • Update: Intuitive Surgical's Firefly For Xi Has Been Approved By The FDA [View article]
    Hi Charlieboy Stevens,

    "With increasingly new patented products, ISRG is, I believe, likely to generate significantly greater revenues and operating income over the longer term." Agreed 100%.

    Aug 28 03:45 AM | 1 Like Like |Link to Comment
  • Update: CalAmp's Agreement With Masternaut Strengthens Its Position In Europe [View article]
    Thank you Strike. Wish you all the best with your investments.
    Aug 27 01:21 PM | Likes Like |Link to Comment
  • Update: Horsehead Raises $50 Million For Potential Acquisitions - Book Partial Profits [View article]
    Hi, I appreciate your comment and insight. Thanks.
    Aug 27 12:55 PM | Likes Like |Link to Comment
  • Update: Cynosure's PicoSure System Bags FDA Approval [View article]
    Agreed. The company is undervalued. Thank you.
    Aug 27 02:02 AM | 1 Like Like |Link to Comment
  • Abbott To Develop Portable Blood Tests For Concussions [View article]
    Sure I will. Thanks.
    Aug 21 12:15 PM | Likes Like |Link to Comment
  • Abbott To Develop Portable Blood Tests For Concussions [View article]
    Hi Minutemen, I appreciate your comment. Abbott may find out brain-specific proteins, so don't be disappointed. Thank you for the insight.
    Aug 21 12:06 PM | Likes Like |Link to Comment
  • Update: NxStage Medical Earnings [View article]
    Hi WalkTheTalk, I believe NXTM's sales growth is definitely sustainable, but as you rightly pointed out, they might not reduce their expense in near future. And that's the real cause of worry, as it may result in not being profitable for a longer period of time than the general expectation on The Street. Oh yes, Fresenius or DaVita may acquire the company any time. Thank you.
    Aug 13 01:42 PM | Likes Like |Link to Comment
  • Update: DexCom Earnings [View article]
    Entirely possible. Thanks.
    Aug 8 01:42 PM | 1 Like Like |Link to Comment
  • Johnson & Johnson's Power Morcellator Recall Could Result In Further Pullback [View article]
    Absolutely. Thanks for the comment.
    Aug 7 01:15 PM | Likes Like |Link to Comment
  • Update: Triumph Group Earnings [View article]
    Hi, I believe that above $50 TGI isn't a safe bet for new investors. At $50 or below, TGI would be a deep value investment for long-term growth oriented players. Those who are already invested in the company should add to their position only at $50 or below, which I believe the stock is slowly approaching. Thanks for your comment, I really appreciate it.
    Aug 6 02:30 AM | Likes Like |Link to Comment